184 related articles for article (PubMed ID: 8410495)
1. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
[TBL] [Abstract][Full Text] [Related]
2. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
3. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma.
Nicholls JM; Agathanggelou A; Fung K; Zeng X; Niedobitek G
J Pathol; 1997 Oct; 183(2):164-8. PubMed ID: 9390028
[TBL] [Abstract][Full Text] [Related]
4. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.
Niedobitek G; Young LS; Sam CK; Brooks L; Prasad U; Rickinson AB
Am J Pathol; 1992 Apr; 140(4):879-87. PubMed ID: 1314028
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.
Niedobitek G; Hansmann ML; Herbst H; Young LS; Dienemann D; Hartmann CA; Finn T; Pitteroff S; Welt A; Anagnostopoulos I
J Pathol; 1991 Sep; 165(1):17-24. PubMed ID: 1659626
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p53 in Hodgkin's disease: lack of correlation with Epstein-Barr virus infection.
Niedobitek G; Rowlands DC; Young LS; Herbst H; Williams A; Hall P; Padfield J; Rooney N; Jones EL
J Pathol; 1993 Feb; 169(2):207-12. PubMed ID: 8383196
[TBL] [Abstract][Full Text] [Related]
7. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].
Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T
Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067
[TBL] [Abstract][Full Text] [Related]
8. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma.
Niedobitek G; Herbst H; Young LS; Rowe M; Dienemann D; Germer C; Stein H
Diagn Mol Pathol; 1992 Jun; 1(2):103-8. PubMed ID: 1342957
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
[TBL] [Abstract][Full Text] [Related]
13. p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma.
Leung SY; Chau KY; Yuen ST; Chu KM; Branicki FJ; Chung LP
Histopathology; 1998 Oct; 33(4):311-7. PubMed ID: 9822919
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
15. Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas.
Shibosawa E; Tsutsumi K; Koizuka I; Hoshikawa M; Takakuwa T
Laryngoscope; 2000 Jan; 110(1):93-7. PubMed ID: 10646722
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
17. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
Murono S; Yoshizaki T; Park CS; Furukawa M
Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
[TBL] [Abstract][Full Text] [Related]
18. Expression of the p53 protein in oral squamous cell carcinomas associated with Epstein-Barr virus.
González-Moles MA; Galindo P; Gutierrez J; Rodriguez-Archilla A; Ruiz-Avilla I; Sanchez-Fernandez E
Microbios; 2000; 102(403):147-54. PubMed ID: 10955828
[TBL] [Abstract][Full Text] [Related]
19. A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma.
Codd JD; Salisbury JR; Packham G; Nicholson LJ
J Pathol; 1999 Apr; 187(5):549-55. PubMed ID: 10398120
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
